|
Accession number;05A0371125
|
| Title;Response Period of Combined Fluvoxamine and Milnacipran Treatment for Depression |
| Author;
MORISHITA SHIGERU
(Kyoto Jujo Hospital, Kyoto, Jpn)
ARITA SEIZABURO
(Kansai Medical School, Osaka, Jpn)
|
Journal Title;Int Med J
|
Journal Code:L4914A
|
ISSN:1341-2051
|
|
VOL.12;NO.1;PAGE.25-26(2005)
|
| Figure&Table&Reference;FIG.1, TBL.1, REF.5 |
| Pub. Country;Japan |
| Language;English |
| Abstract;Objective: In providing drug treatment, it is important to appear the faster onset of response to patients. Antidepressants typically take two to four weeks to provide substantial benefit. The purpose of this clinical practice was to determine the response period of combined fluvoxamine and milnacipran treatment for depression. Design: Open clinical study. Methods: Open clinical study was carried out among twenty-one depression patients. They were receiving 50 mg of fluvoxamine and 50 mg of milnacipran to treat depression. Results: The cumulative percentage of responder receiving fluvoxamine and milnacipran reached over 80% after three weeks. Conclusion: Combined treatment may have a faster onset of response than monotherapy treatment. (author abst.) |
|
|
|
Related Articles;
|
